THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.qduh.cn

Clinical Trials

Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer

Phase 4

Recruiting

Conditions: Non-small-cell Lung Cancer (NSCLC)

Interventions: Drug: Tislelizumab
Drug: Pemetrexed (Non-squamous NSCLC) or Nab-paclitaxel(Squamous NSCLC)
Drug: Carboplatin or Cisplatin
Procedure: Surgery

First Posted Date: 2024-04-10

Last Posted Date: 2024-04-10

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 30

Registration Number: NCT06357598

Locations: 🇨🇳
the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection

Not Applicable

Recruiting

Conditions: Suture, Complication

Interventions: Device: Non-absorbable Suture
Device: Absorbable Suture

First Posted Date: 2024-04-03

Last Posted Date: 2024-04-03

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 40

Registration Number: NCT06344962

Locations: 🇨🇳
the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

Not yet recruiting

Conditions: Breast Cancer
Breast Diseases
Neoplasms

Interventions: Drug: Letrozole or Anastrozole
Drug: Abemaciclib and Fulvestrant
Drug: Fulvestrant
Drug: Abemaciclib and Letrozole/Anastrozole

First Posted Date: 2024-04-02

Last Posted Date: 2024-05-10

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 200

Registration Number: NCT06341283

Locations: 🇨🇳
Clinical Research Center, Qingdao, Shandong, China

Comparative Pharmacokinetic Study of Aprepitant Injection in Humans

Phase 1

Not yet recruiting

Conditions: Healthy

Interventions: Drug: Test (T) Aprepitant injection
Drug: Reference (R) Aprepitant injection

First Posted Date: 2024-01-26

Last Posted Date: 2024-01-26

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 24

Registration Number: NCT06226506

Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects

Phase 1

Not yet recruiting

Conditions: Healthy

Interventions: Drug: Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
Drug: Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)

First Posted Date: 2023-12-22

Last Posted Date: 2023-12-22

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 36

Registration Number: NCT06180720

The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy

Completed

Conditions: Bronchoscopy

Interventions: Drug: Midazolam and sufentanil
Drug: Midazolam, sufentanil and propofol
Drug: Remazolam and sufentanil.
Drug: Remazolam, sufentanil and propofol

First Posted Date: 2023-11-03

Last Posted Date: 2024-01-31

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 424

Registration Number: NCT06116955

Locations: 🇨🇳
Affiliated Hospital of Qingdao University, Shandong, Qingdao, China

Bioequivalence Study of Bilastine Tablets in Healthy Chinese Subjects

Phase 1

Not yet recruiting

Conditions: Healthy

Interventions: Drug: Test (T) Bilastine
Drug: Reference (R) Bilastine

First Posted Date: 2023-10-24

Last Posted Date: 2023-10-24

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 40

Registration Number: NCT06098261

Quantitative Detection of CEA mRNA in the Smog and Tissue Exudate Whole Process Collected During Laparoscopic (Robotic) Radical Gastrectomy in Gastric Cancer Patients

Recruiting

Conditions: Gastric Cancer

Interventions: Procedure: Radical Gastric Cancer Surgery

First Posted Date: 2023-10-10

Last Posted Date: 2023-10-10

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 80

Registration Number: NCT06076265

Locations: 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body

Phase 1

Recruiting

Conditions: Bioequivalence
Schizophrenia

First Posted Date: 2023-10-04

Last Posted Date: 2023-10-04

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 100

Registration Number: NCT06066112

Locations: 🇨🇳
The Affiliated Hospital of Qingdao University Phase I Clinical Research Center, Qingdao, Shandong, China

Effects of Omega-3 Fish Oil Fat Emulsion on Rehabilitation and Immune Function After Radical Surgery Combined With Intraperitoneal Hyperthermic Infusion Chemotherapy in Patients With Locally Advanced Gastric Cancer

Recruiting

Conditions: Fish Oils
Perfusion; Complications
Stomach Neoplasms
Nutrition Aspect of Cancer
Chemotherapy Effect
Immunisation Reaction

Interventions: Drug: Omega-3 fish oil fat emulsion

First Posted Date: 2023-09-21

Last Posted Date: 2023-09-21

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 200

Registration Number: NCT06047158

Locations: 🇨🇳
Ruiqing Liu, Qingdao, Shan Dong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy